Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Effecti-Cal
- Development stage
- Phase 4
- Lead developer
- Jamieson Wellness
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Effecti-Cal is a multi-source calcium supplement developed by Jamieson Wellness to support bone health and prevent osteoporosis. The formulation features a complex of calcium from five different sources—carbonate, citrate, fumarate, malate, and succinate—to enhance bioavailability and ensure consistent elemental calcium delivery. It is typically co-formulated with Vitamin D3 (cholecalciferol), which acts as an agonist for the Vitamin D receptor (VDR) to stimulate the synthesis of calcium-transporting proteins in the intestine, thereby increasing calcium absorption. By maintaining adequate serum calcium levels and supporting bone mineral density, Effecti-Cal helps reduce the risk of fractures and supports overall musculoskeletal function.
- Brand names
- Effecti-Cal
- Other names
- Jamieson Effecti-Cal
02
Targets
CaSR (Extracellular calcium-sensing receptor)
Beyond the preview
Go deeper on Effecti-Cal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Effecti-Cal.